3rd Quarter - Report

MEDCO HEALTH SOLUTIONS, INC for MEDCO HEALTH SOLUTIONS INC

Firm
Client
Income
—
Expenses
$915,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory policies related to health reform implementation: structure, drug benefits, disclosure; Regulatory implementation of HITECH, Accounting of Disclosures; FDA issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs) H.R. 979 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act; all sections H.R. 1041 - Fairness in Medicare Bidding Act (FIMBA); all sections H.R. 1004 - Medical FSA Improvement Act of 2011; all sections H.R. 5 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act of 2011; all sections

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —
RYAN SADLER —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 979 (112th), H.R. 1004 (112th), H.R. 1041 (112th), H.R. 5 (112th)

Postal POS

Legislation related to mail delivery frequency H.R. 2309, S. 1625 - The Postal Reform Act of 2011; sections 111 - 114 S. 353 - U.S. Postal Service Improvements Act of 2011; all sections S. 1010 - Postal Operations Sustainment and Transformation Act of 2011; all sections H.R. 1262 - Reform the Postal Service for the 21st Century Act

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: S. 353 (112th), H.R. 1262 (112th), S. 1010 (112th), H.R. 2309 (112th), S. 1625 (112th)

Pharmacy PHA

Issues related to the FEHBP program benefit; Electronic prescribing; PBM disclosure requirements; regulatory implementation of a pathway for the approval of biosimilars H.R. 979 - The FEHBP Drug Integrity, Transparency, and Cost Savings Act of 2011; all sections S. 1058 - The Pharmacy Competition and Consumer Choice Act of 2011; all sections H.R. 1409 - The Quality Health Care Coalition Act of 2011; all sections H.R. 1946 - Preserving Hometown Pharmacies Act of 2011; all sections H.R. 1839 - Community Pharmacists Fairness Act of 2011; all sections

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —
DOLLY JUDGE New staff assistant, former Rep. Dan Mica
RYAN SADLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: S. 1058 (112th), H.R. 1946 (112th), H.R. 1839 (112th), H.R. 979 (112th), H.R. 1409 (112th)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D; healthcare regulations; closing of the Part D coverage gap; proposed antitrust exemptions for certain pharmacies; IVIG payment structure; Medicare demonstration projects for durable medical equipment; home infusion; PBM disclosure provisions; changes to drug benefits offered under the FEHBP program; increasing healthcare value; competitive bidding (H.R. 2195, S. 1203, H.R. 1845, S. 960, H.R. 979, H.R. 1041)

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —
DOLLY JUDGE New staff assistant, former Rep. Dan Mica
RYAN SADLER —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 960 (112th), H.R. 1041 (112th), H.R. 979 (112th), S. 1203 (112th), H.R. 1845 (112th), H.R. 2195 (112th)

Labor Issues/Antitrust/Workplace LBR

Advocacy surrounding proposed corporate merger

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
PETER HARTY —

Contacted: Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Affiliated organisations

OrganisationLocation
ACCREDO HEALTH GROUP, INC. Memphis, TN, US
LIBERTY MEDICAL SUPPLY, INC. Port St. Lucie, FL, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.